user: GUEST
width: 600



DescriptionRecName: Full=Zinc transporter ZIP8; AltName: Full=BCG-induced integral membrane protein in monocyte clone 103 protein; AltName: Full=LIV-1 subfamily of ZIP zinc transporter 6; Short=LZT-Hs6; AltName: Full=Solute carrier family 39 member 8; AltName: Full=Zrt- and Irt-like protein 8; Short=ZIP-8;
MyHits logo
MyHits synonymsS39A8_HUMAN , Q9C0K1 , B4E2H3 , Q96SM9 , Q9BVC0 , Q9NSA4 , E5C03F4576E11E2F
match map segment
ipfam:Zip  
Legends: 1, N-linked (GlcNAc...) asparagine. {ECO:0000255}; 2, VARIANT V -> M (in CDG2N; dbSNP:rs373562040). {ECO:0000269|PubMed:26637979}; 3, VARIANT G -> R (in CDG2N; lowered Mn and Zn blood levels and increased Mn and Zn urine levels in affected individuals; dbSNP:rs778210210). {ECO:0000269|PubMed:26637978, ECO:0000269|PubMed:26637979}; 4, VARIANT G -> C (in CDG2N; dbSNP:rs779241085). {ECO:0000269|PubMed:26637979}; 5, VARIANT S -> T (in CDG2N; dbSNP:rs864309660). {ECO:0000269|PubMed:26637979}; 6, VARIANT I -> N (in CDG2N; no detectable serum or urinary manganese levels in an affected individual who also carries R-38 mutation; dbSNP:rs864309659). {ECO:0000269|PubMed:26637979}; 7, VARIANT A -> T (in dbSNP:rs13107325); 8, CONFLICT K -> E (in Ref. 3; BAB55268). {ECO:0000305}; 9, TOPO_DOM Extracellular. {ECO:0000255}; 10, TRANSMEM Helical. {ECO:0000255}; 11, TOPO_DOM Cytoplasmic. {ECO:0000255}; 12, MOTIF XEXPHE-motif; 13, VAR_SEQ Missing (in isoform 2). {ECO:0000303|PubMed:14702039}; 14, VAR_SEQ QLHFN -> MHQHA (in isoform 2). {ECO:0000303|PubMed:14702039}; 15, VAR_SEQ VTGRKTDFTFFMIQNAGMLTGFTAILLITLYAGEIELE -> IIKWATDDIKSQLHLLWIYTAR (in isoform 3). {ECO:0000303|PubMed:14702039}.
ID   S39A8_HUMAN             Reviewed;         460 AA.
AC   Q9C0K1; B4E2H3; Q96SM9; Q9BVC0; Q9NSA4;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   10-MAY-2017, entry version 121.
DE   RecName: Full=Zinc transporter ZIP8;
DE   AltName: Full=BCG-induced integral membrane protein in monocyte clone 103 protein;
DE   AltName: Full=LIV-1 subfamily of ZIP zinc transporter 6;
DE            Short=LZT-Hs6;
DE   AltName: Full=Solute carrier family 39 member 8;
DE   AltName: Full=Zrt- and Irt-like protein 8;
DE            Short=ZIP-8;
GN   Name=SLC39A8; Synonyms=BIGM103, ZIP8; ORFNames=PP3105;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, INDUCTION BY PHORBOL ESTER; TNFA AND
RP   MYCOBACTERIUM BOVIS BCG CELL WALL, AND FUNCTION.
RX   PubMed=12504855; DOI=10.1006/geno.2002.7000;
RA   Begum N.A., Kobayashi M., Moriwaki Y., Matsumoto M., Toyoshima K.,
RA   Seya T.;
RT   "Mycobacterium bovis BCG cell wall and lipopolysaccharide induce a
RT   novel gene, BIGM103, encoding a 7-TM protein: identification of a new
RT   protein family having Zn-transporter and Zn-metalloprotease
RT   signatures.";
RL   Genomics 80:630-645(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H.,
RA   Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y.,
RA   Shu H., Chen X., Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S.,
RA   Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   VARIANT CDG2N ARG-38, AND FUNCTION.
RX   PubMed=26637978; DOI=10.1016/j.ajhg.2015.11.002;
RG   Care4Rare Canada Consortium;
RA   Boycott K.M., Beaulieu C.L., Kernohan K.D., Gebril O.H., Mhanni A.,
RA   Chudley A.E., Redl D., Qin W., Hampson S., Kuery S., Tetreault M.,
RA   Puffenberger E.G., Scott J.N., Bezieau S., Reis A., Uebe S.,
RA   Schumacher J., Hegele R.A., McLeod D.R., Galvez-Peralta M.,
RA   Majewski J., Ramaekers V.T., Nebert D.W., Innes A.M.,
RA   Parboosingh J.S., Abou Jamra R.;
RT   "Autosomal-recessive intellectual disability with cerebellar atrophy
RT   syndrome caused by mutation of the manganese and zinc transporter gene
RT   SLC39A8.";
RL   Am. J. Hum. Genet. 97:886-893(2015).
RN   [8]
RP   VARIANTS CDG2N MET-33; ARG-38; CYS-204; THR-335 AND ASN-340.
RX   PubMed=26637979; DOI=10.1016/j.ajhg.2015.11.003;
RA   Park J.H., Hogrebe M., Grueneberg M., DuChesne I.,
RA   von der Heiden A.L., Reunert J., Schlingmann K.P., Boycott K.M.,
RA   Beaulieu C.L., Mhanni A.A., Innes A.M., Hoertnagel K., Biskup S.,
RA   Gleixner E.M., Kurlemann G., Fiedler B., Omran H., Rutsch F., Wada Y.,
RA   Tsiakas K., Santer R., Nebert D.W., Rust S., Marquardt T.;
RT   "SLC39A8 deficiency: a disorder of manganese transport and
RT   glycosylation.";
RL   Am. J. Hum. Genet. 97:894-903(2015).
CC   -!- FUNCTION: Acts as a manganese and zinc influx transporter
CC       (PubMed:12504855, PubMed:26637978). Plays a role in manganese
CC       reabsorption in the proximal tubule of the kidney and in manganese
CC       uptake into the brain (PubMed:26637978).
CC       {ECO:0000269|PubMed:12504855, ECO:0000305|PubMed:26637978}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}. Note=Associated with the
CC       lysosomal/endosomal compartment following transfection.
CC       {ECO:0000269|PubMed:12504855}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9C0K1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9C0K1-2; Sequence=VSP_029884, VSP_029885;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q9C0K1-3; Sequence=VSP_043675;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in thymus, placenta, lung, liver,
CC       pancreas and, to a lower extent, in spleen, testis, ovary, small
CC       intestine, colon, leukocyte, heart. Highest expression is observed
CC       in pancreas. {ECO:0000269|PubMed:12504855}.
CC   -!- INDUCTION: By live and heat-killed Mycobacterium bovis bacterial
CC       cell wall and inflammatory cytokines like TNF. Down-regulated
CC       following phorbol ester treatment. {ECO:0000269|PubMed:12504855}.
CC   -!- DISEASE: Congenital disorder of glycosylation 2N (CDG2N)
CC       [MIM:616721]: A form of congenital disorder of glycosylation, a
CC       genetically heterogeneous group of autosomal recessive,
CC       multisystem disorders caused by a defect in glycoprotein
CC       biosynthesis and characterized by under-glycosylated serum
CC       glycoproteins. Congenital disorders of glycosylation result in a
CC       wide variety of clinical features, such as defects in the nervous
CC       system development, psychomotor retardation, dysmorphic features,
CC       hypotonia, coagulation disorders, and immunodeficiency. The broad
CC       spectrum of features reflects the critical role of N-glycoproteins
CC       during embryonic development, differentiation, and maintenance of
CC       cell functions. {ECO:0000269|PubMed:26637978,
CC       ECO:0000269|PubMed:26637979}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ZIP transporter (TC 2.A.5) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB020970; BAA96442.1; -; mRNA.
DR   EMBL; AB040120; BAB21559.1; -; mRNA.
DR   EMBL; AK027652; BAB55268.1; -; mRNA.
DR   EMBL; AK304274; BAG65135.1; -; mRNA.
DR   EMBL; AF193052; AAG22480.1; -; mRNA.
DR   EMBL; AC098487; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP002023; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471057; EAX06130.1; -; Genomic_DNA.
DR   EMBL; BC001320; AAH01320.1; -; mRNA.
DR   EMBL; BC012125; AAH12125.1; -; mRNA.
DR   CCDS; CCDS3656.1; -. [Q9C0K1-1]
DR   CCDS; CCDS47117.1; -. [Q9C0K1-3]
DR   RefSeq; NP_001128618.1; NM_001135146.1. [Q9C0K1-1]
DR   RefSeq; NP_001128619.1; NM_001135147.1. [Q9C0K1-3]
DR   RefSeq; NP_001128620.1; NM_001135148.1. [Q9C0K1-2]
DR   RefSeq; NP_071437.3; NM_022154.5. [Q9C0K1-1]
DR   RefSeq; XP_005263234.1; XM_005263177.1. [Q9C0K1-1]
DR   RefSeq; XP_016864029.1; XM_017008540.1. [Q9C0K1-1]
DR   RefSeq; XP_016864030.1; XM_017008541.1. [Q9C0K1-2]
DR   UniGene; Hs.288034; -.
DR   ProteinModelPortal; Q9C0K1; -.
DR   SMR; Q9C0K1; -.
DR   BioGrid; 122072; 26.
DR   STRING; 9606.ENSP00000349174; -.
DR   TCDB; 2.A.5.4.15; the zinc (zn(2+))-iron (fe(2+)) permease (zip) family.
DR   iPTMnet; Q9C0K1; -.
DR   PhosphoSitePlus; Q9C0K1; -.
DR   BioMuta; SLC39A8; -.
DR   DMDM; 74733496; -.
DR   EPD; Q9C0K1; -.
DR   MaxQB; Q9C0K1; -.
DR   PaxDb; Q9C0K1; -.
DR   PeptideAtlas; Q9C0K1; -.
DR   PRIDE; Q9C0K1; -.
DR   DNASU; 64116; -.
DR   Ensembl; ENST00000356736; ENSP00000349174; ENSG00000138821. [Q9C0K1-1]
DR   Ensembl; ENST00000394833; ENSP00000378310; ENSG00000138821. [Q9C0K1-1]
DR   Ensembl; ENST00000424970; ENSP00000394548; ENSG00000138821. [Q9C0K1-3]
DR   GeneID; 64116; -.
DR   KEGG; hsa:64116; -.
DR   UCSC; uc003hwb.2; human. [Q9C0K1-1]
DR   CTD; 64116; -.
DR   DisGeNET; 64116; -.
DR   GeneCards; SLC39A8; -.
DR   HGNC; HGNC:20862; SLC39A8.
DR   HPA; HPA038832; -.
DR   HPA; HPA038833; -.
DR   MalaCards; SLC39A8; -.
DR   MIM; 608732; gene.
DR   MIM; 616721; phenotype.
DR   neXtProt; NX_Q9C0K1; -.
DR   OpenTargets; ENSG00000138821; -.
DR   PharmGKB; PA134931507; -.
DR   eggNOG; KOG2693; Eukaryota.
DR   eggNOG; COG0428; LUCA.
DR   GeneTree; ENSGT00760000119115; -.
DR   HOGENOM; HOG000070225; -.
DR   HOVERGEN; HBG108450; -.
DR   InParanoid; Q9C0K1; -.
DR   KO; K14714; -.
DR   OMA; FFVERVL; -.
DR   OrthoDB; EOG091G064Y; -.
DR   PhylomeDB; Q9C0K1; -.
DR   TreeFam; TF318470; -.
DR   Reactome; R-HSA-442380; Zinc influx into cells by the SLC39 gene family.
DR   ChiTaRS; SLC39A8; human.
DR   GenomeRNAi; 64116; -.
DR   PRO; PR:Q9C0K1; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000138821; -.
DR   CleanEx; HS_SLC39A8; -.
DR   ExpressionAtlas; Q9C0K1; baseline and differential.
DR   Genevisible; Q9C0K1; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0031090; C:organelle membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005385; F:zinc ion transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0070574; P:cadmium ion transmembrane transport; IEA:Ensembl.
DR   GO; GO:0006882; P:cellular zinc ion homeostasis; IBA:GO_Central.
DR   GO; GO:0071578; P:zinc II ion transmembrane import; IBA:GO_Central.
DR   GO; GO:0006829; P:zinc II ion transport; IMP:UniProtKB.
DR   InterPro; IPR003689; ZIP.
DR   Pfam; PF02535; Zip; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome;
KW   Congenital disorder of glycosylation; Glycoprotein; Ion transport;
KW   Membrane; Polymorphism; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Zinc; Zinc transport.
FT   CHAIN         1    460       Zinc transporter ZIP8.
FT                                /FTId=PRO_0000312707.
FT   TOPO_DOM      1      8       Extracellular. {ECO:0000255}.
FT   TRANSMEM      9     29       Helical. {ECO:0000255}.
FT   TOPO_DOM     30    132       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    133    153       Helical. {ECO:0000255}.
FT   TOPO_DOM    154    160       Extracellular. {ECO:0000255}.
FT   TRANSMEM    161    181       Helical. {ECO:0000255}.
FT   TOPO_DOM    182    191       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    192    212       Helical. {ECO:0000255}.
FT   TOPO_DOM    213    302       Extracellular. {ECO:0000255}.
FT   TRANSMEM    303    323       Helical. {ECO:0000255}.
FT   TOPO_DOM    324    365       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    366    386       Helical. {ECO:0000255}.
FT   TOPO_DOM    387    388       Extracellular. {ECO:0000255}.
FT   TRANSMEM    389    409       Helical. {ECO:0000255}.
FT   TOPO_DOM    410    429       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    430    450       Helical. {ECO:0000255}.
FT   TOPO_DOM    451    460       Extracellular. {ECO:0000255}.
FT   MOTIF       343    348       XEXPHE-motif.
FT   CARBOHYD    273    273       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1     67       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_029884.
FT   VAR_SEQ      68     72       QLHFN -> MHQHA (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_029885.
FT   VAR_SEQ     423    460       VTGRKTDFTFFMIQNAGMLTGFTAILLITLYAGEIELE ->
FT                                IIKWATDDIKSQLHLLWIYTAR (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043675.
FT   VARIANT      33     33       V -> M (in CDG2N; dbSNP:rs373562040).
FT                                {ECO:0000269|PubMed:26637979}.
FT                                /FTId=VAR_076241.
FT   VARIANT      38     38       G -> R (in CDG2N; lowered Mn and Zn blood
FT                                levels and increased Mn and Zn urine
FT                                levels in affected individuals;
FT                                dbSNP:rs778210210).
FT                                {ECO:0000269|PubMed:26637978,
FT                                ECO:0000269|PubMed:26637979}.
FT                                /FTId=VAR_076242.
FT   VARIANT     204    204       G -> C (in CDG2N; dbSNP:rs779241085).
FT                                {ECO:0000269|PubMed:26637979}.
FT                                /FTId=VAR_076243.
FT   VARIANT     335    335       S -> T (in CDG2N; dbSNP:rs864309660).
FT                                {ECO:0000269|PubMed:26637979}.
FT                                /FTId=VAR_076244.
FT   VARIANT     340    340       I -> N (in CDG2N; no detectable serum or
FT                                urinary manganese levels in an affected
FT                                individual who also carries R-38
FT                                mutation; dbSNP:rs864309659).
FT                                {ECO:0000269|PubMed:26637979}.
FT                                /FTId=VAR_076245.
FT   VARIANT     391    391       A -> T (in dbSNP:rs13107325).
FT                                /FTId=VAR_037551.
FT   CONFLICT    241    241       K -> E (in Ref. 3; BAB55268).
FT                                {ECO:0000305}.
CC   --------------------------------------------------------------------------
CC   The following FT lines are automated annotations from the MyHits database.
CC   --------------------------------------------------------------------------
FT   MYHIT       127    450       ipfam:Zip [T]
SQ   SEQUENCE   460 AA;  49631 MW;  E5C03F4576E11E2F CRC64;
     MAPGRAVAGL LLLAAAGLGG VAEGPGLAFS EDVLSVFGAN LSLSAAQLQH LLEQMGAASR
     VGVPEPGQLH FNQCLTAEEI FSLHGFSNAT QITSSKFSVI CPAVLQQLNF HPCEDRPKHK
     TRPSHSEVWG YGFLSVTIIN LASLLGLILT PLIKKSYFPK ILTFFVGLAI GTLFSNAIFQ
     LIPEAFGFDP KVDSYVEKAV AVFGGFYLLF FFERMLKMLL KTYGQNGHTH FGNDNFGPQE
     KTHQPKALPA INGVTCYANP AVTEANGHIH FDNVSVVSLQ DGKKEPSSCT CLKGPKLSEI
     GTIAWMITLC DALHNFIDGL AIGASCTLSL LQGLSTSIAI LCEEFPHELG DFVILLNAGM
     STRQALLFNF LSACSCYVGL AFGILVGNNF APNIIFALAG GMFLYISLAD MFPEMNDMLR
     EKVTGRKTDF TFFMIQNAGM LTGFTAILLI TLYAGEIELE
//